F-group (family)
325.1.5.1 Ribosomal_L16
Ligands and drugs
3,317
Member domains
1,013
with ligand contacts (≤ 4 Å)
30.5% of members
635
with DrugDomain annotations
19.1% of members
24
with a DrugBank compound
0.7% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 325.1.5.1 belongs to X-group 325 alpha/beta-Hammerhead/Barrel-sandwich hybrid, which binds 8.9 ligand superclasses per 20 proteins, broader than 75% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00134 | MET | Methionine | 6 |
| DB03566 | SPD | Spermidine | 2 |
| DB00149 | LEU | Leucine | 1 |
| DB02494 | — | (S)-3-phenyllactic acid | 1 |
| DB04729 | LLL | Gentamicin C1a | 1 |
| DB07374 | — | — | 1 |
| DB08437 | — | Puromycin | 1 |
| DB11638 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 848 |
| Kmetal | POTASSIUM ION | 95 |
| NAmetal | SODIUM ION | 67 |
| OHX | osmium (III) hexammine | 61 |
| SRmetal | STRONTIUM ION | 30 |
| UNX | UNKNOWN ATOM OR ION | 12 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 10 |
| PUT | 1,4-DIAMINOBUTANE | 10 |
| MNmetal | MANGANESE (II) ION | 4 |
| PAR | PAROMOMYCIN | 4 |
| SPD | SPERMIDINE | 3 |
| 6O1 | Evernimicin | 2 |
| 6UQ | (2R,3S,4R,6S)-4-hydroxy-6-{[(2R,3aR,4R,4'R,5'S,6S,6'R,7aR)-4'-hydroxy-6-{[(2S,3R,4R,5S,6R)-3-hydroxy-2-{[(2R,3S,4S,5S,6S)-4-hydroxy-6-({(2R,3aS,3a'R,6S,6'R,7R,7'R,7aR,7a'R)-7'-hydroxy-7'-[(1S)-1-hydroxyethyl]-6'-methyl-7-[(2-methylpropanoyl)oxy]octahydro-4H-2,4'-spirobi[[1,3]dioxolo[4,5-c]pyran]-6-yl}oxy)-5-methoxy-2-(methoxymethyl)tetrahydro-2H-pyran-3-yl]oxy}-5-methoxy-6-methyltetrahydro-2H-pyran-4-yl]oxy}-4,6',7a-trimethyloctahydro-4H-spiro[1,3-dioxolo[4,5-c]pyran-2,2'-pyran]-5'-yl]oxy}-2-methyltetrahydro-2H-pyran-3-yl 3,5-dichloro-4-hydroxy-2-methoxy-6-methylbenzoate (non-preferred name) | 2 |
| FSD | amicetin | 2 |
| LLL | (2R,3R,4R,5R)-2-((1S,2S,3R,4S,6R)-4,6-DIAMINO-3-((2R,3R,6S)-3-AMINO-6-(AMINOMETHYL)-TETRAHYDRO-2H-PYRAN-2-YLOXY)-2-HYDROXYCYCLOHEXYLOXY)-5-METHYL-4-(METHYLAMINO)-TETRAHYDRO-2H-PYRAN-3,5-DIOL | 2 |
| PRO | PROLINE | 2 |
| 6NO | Avilamycin | 1 |
| 84G | Arbekacin | 1 |
| EVN | (2R,3R,4R,6S)-6-{[(2R,3aR,4R,4'R,5'S,6S,6'R,7S,7aR)-6-{[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4S,5S,6S)-6-({(2R,3aS,3a'R,6S,7R,7'R,7aS,7a'S)-7'-[(2,4-dihydroxy-6-methylbenzoyl)oxy]-7-hydroxyoctahydro-4H-2,4'-spirobi[[1,3]dioxolo[4,5-c]pyran]-6-yl}oxy)-4-hydroxy-5-methoxy-2-(methoxymethyl)tetrahydro-2H-pyran-3-yl]oxy}-3-hydroxy-5-methoxy-6-methyltetrahydro-2H-pyran-4-yl]oxy}-4',7-dihydroxy-4,6',7a-trimethyloctahydro-4H-spiro[1,3-dioxolo[4,5-c]pyran-2,2'-pyran]-5'-yl]oxy}-4-{[(2R,4S,5R,6S)-5-methoxy-4,6-dimethyl-4-nitrotetrahydro-2H-pyran-2-yl]oxy}-2-methyltetrahydro-2H-pyran-3-yl 3,5-dichloro-4-hydroxy-2-methoxy-6-methylbenzoate (non-preferred name) | 1 |
| KAN | KANAMYCIN A | 1 |